1 Min Read
Big Pharma companies are still betting big on AI, with major players pouring resources into agent platforms. The goal: unify fragmented data, streamline operations from clinical trials to sales, and enable more personalized healthcare provider interactions. Novartis has selected Salesforce’s Agentforce Life Sciences for a global rollout over the next five years. The deal follows… The post Novartis picks Salesforce’s Agentforce as pharma bets big on AI agents appeared first on Drug Discovery and Development.
Work & Theory on January 6, 2026
Uncategorized